Advertisement

Pediatric Nephrology

, Volume 29, Issue 1, pp 161–162 | Cite as

Recovery of native erythropoietin in a patient with erythropoietin-associated pure red cell aplasia

  • Kristina M. Prus
  • Mohamad M. Al-RahawanEmail author
Letter to the Editors

Keywords

Erythropoietin Darbepoetin Alfa Focal Segmental Glomerulosclerosis Transfusion Independence Aranesp 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Mattison P, Upadhyay K, Wilcox JE, Moudgil A, Silverstein DM (2010) Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient. Pediatr Nephrol 25:971–976PubMedCrossRefGoogle Scholar
  2. 2.
    McKoy JM, Stonecash RE, Cournoyer D, Rossert J, Nissenson AR, Raisch DW, Casadevall N, Bennett CL (2008) Epoetin-associated pure red cell aplasia: Past, present, and future considerations. Transfusion 48:1754–1762PubMedCrossRefGoogle Scholar
  3. 3.
    Macdougall IC, Roger SD, de Francisco A, Goldsmith DJ, Schellekens H, Ebbers H, Jelkmann W, London G, Casadevall N, Hörl WH, Kemeny DM, Pollock C (2012) Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights. Kidney Int 81:727–32PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2013

Authors and Affiliations

  1. 1.University of Illinois College of Medicine at PeoriaPeoriaUSA
  2. 2.St. Jude Children’s Research HospitalMemphisUSA

Personalised recommendations